Savara (SVRA) Cash & Equivalents (2010 - 2026)

Savara's (SVRA) quarterly Cash & Equivalents came in at $38.8 million in Q1 2026, up 97.96% year-on-year from $19.6 million in Q1 2025, and up 16.94% on a QoQ basis from $33.2 million in Q4 2025.

Savara (SVRA) Cash & Equivalents (2010 - 2026) Analysis & Trends

Savara (SVRA) has 17 years of Cash & Equivalents data on file, last reported at $38.8 million in Q1 2026.

  • On a quarterly basis, Cash & Equivalents rose 97.96% year-over-year to $38.8 million in Q1 2026; TTM through Mar 2026 was $38.8 million, a 97.96% increase from a year earlier, with the FY2025 full-year figure at $33.2 million, up 119.33% from the prior year.
  • Cash & Equivalents for Q1 2026 stood at $38.8 million, up from $33.2 million in the prior quarter.
  • Over the last five years, Cash & Equivalents for SVRA reached as high as $119.8 million in Q3 2022 and fell as low as $15.1 million in Q4 2024.
  • Historically, Cash & Equivalents has averaged $38.8 million across 5 years, with a median of $26.6 million in 2023.
  • Across the five-year window, Cash & Equivalents jumped 168.01% in 2022 and tumbled 76.88% in 2023, its largest moves.
  • Year by year, Cash & Equivalents stood at $52.1 million in 2022, then slumped by 48.97% to $26.6 million in 2023, then plunged by 43.1% to $15.1 million in 2024, then surged by 119.33% to $33.2 million in 2025, then climbed by 16.94% to $38.8 million in 2026.
  • Per Business Quant data, the three most recent Cash & Equivalents figures were $38.8 million in Q1 2026, $33.2 million in Q4 2025, and $16.3 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 82.45 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 61.40 Mn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 4.79 Bn
4 NuCana 279.75 Bn 279.75 Bn - 32.26 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 5.49 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 2.96 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 3.58 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 440.94 Mn
10 Savara 1.24 Bn 1.24 Bn - 38.80 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 38.80 Mn
Dec 31, 2025 33.18 Mn
Sep 30, 2025 16.28 Mn
Jun 30, 2025 17.40 Mn
Mar 31, 2025 19.60 Mn
Dec 31, 2024 15.13 Mn
Sep 30, 2024 21.43 Mn
Jun 30, 2024 23.90 Mn
Mar 31, 2024 16.80 Mn
Dec 31, 2023 26.59 Mn
Sep 30, 2023 27.70 Mn
Jun 30, 2023 22.70 Mn
Mar 31, 2023 34.00 Mn
Dec 31, 2022 52.10 Mn
Sep 30, 2022 119.80 Mn
Jun 30, 2022 95.15 Mn
Mar 31, 2022 79.23 Mn
Dec 31, 2021 34.01 Mn
Sep 30, 2021 44.70 Mn
Jun 30, 2021 40.65 Mn